Key Takeaways

Novo Nordisk is offering Ozempic and Wegovy for $199 to $349 per month

Nearly 1 in 5 U.S. adults has taken a GLP-1 drug, data shows

Experts say lower prices may help access but could also cause employers to drop insurance coverage

WEDNESDAY, Nov. 19, 2025 (HealthDay News) — People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.

The company announced that through the end of March, patients with prescriptions can buy the two lowest doses of Ozempic and Wegovy for $199 a month for two months.

After that, the monthly cost rises to $349. The discounts can be accessed through the drugs’ websites and used at pharmacies or through telehealth.

The $199 offer only applie

See Full Page